| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
From the Division of Bacteriology and Immunology,*
Haartman Institute, University of Helsinki, and the HUCH
Diagnostics
and Department of
Medicine
, University Central
Hospital, Helsinki, Finland
 |
Abstract |
|---|
 Top Abstract IntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
|
Introduction |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
We have earlier characterized monoclonal antibodies specific for rat podocalyxin.3,4 In preliminary experiments we noticed that after intravenous injections into rats the antibodies bound to endothelial cells3 and sometimes were detected at the surface of platelets in glomeruli (A. Miettinen, unpublished observations). This prompted us to study whether podocalyxin is present in platelets. Here we show, using biochemical, immunological, and histological techniques, that podocalyxin is expressed in rat platelets and megakaryocytes. We have also partially cloned rat glomerular podocalyxin, present the first sequence data of it, and demonstrate using molecular biology techniques that podocalyxin mRNA is present in megakaryocytes and platelets.
|
Materials and Methods |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
All reagents were of analytical grade, and their sources, if not given below, were as given in previous publications.3,4,11,12 Sprague-Dawley rats were from the Division of Bacteriology and Immunology (University of Helsinki, Finland). The use of experimental animals was approved by the Ethical Committee of the Haartman Institute (University of Helsinki).
Antibodies
The monoclonal mouse anti-rat glomerular podocalyxin antibodies of clones 5A (IgG1) and 1A (IgG2b) as well as the monoclonal antibodies against rat gp330/megalin (clone 20B, IgG1) and O-acetyl GD3 ganglioside (clone 27A, IgG3)4,13 have been described. The controls included also monoclonal antibodies against rat annexin I (clone 34E11, IgG3; Tissari and A. Miettinen, unpublished observations). Mouse monoclonal LYP-20 antibodies against human CD62P (P-selectin) cross-reacting with rat CD62P14 were obtained from Dr. E. Chignier (INSERM, Lyon, France).
Polyclonal antibodies against podocalyxin were made by immunizing two
rabbits with podocalyxin purified from isolated rat
glomeruli4
solubilized in 1% Triton X-100. Podocalyxin was
obtained from the extract by sequential use of wheat germ agglutinin
affinity chromatography,1
preparative sodium dodecyl
sulfate (SDS) polyacrylamide gel electrophoresis (PAGE), and
electroelution (Isco model 1750, Lincoln, NE). The purity of the
isolated material was analyzed by silver staining of SDS-PAGE gels
(Figure 3a
; see below) and by Western blotting with the monoclonal
antibodies before it was used for immunizations or for amino acid
sequencing (Dr. Marc Baumann, Department of Medical Biochemistry,
University of Helsinki). The rabbits received 500 µg of the isolated
protein divided into four injections given 1 month apart. Sera were
collected before and 2 weeks after the last injection. The first
immunization was given with Freund's complete (Difco Laboratories,
Detroit, MI) and the booster injections with incomplete adjuvant. The
specificity of the antisera was tested by immunofluorescence (IF) on
kidney sections (Figure 1a)
,
by Western blotting (Figure 3c)
, and by immunoprecipitation of
glomerular extracts (results not shown). IgG fractions from the
hybridoma supernatants or one of the rabbit sera (290) were isolated by
protein A affinity chromatography,4
and the rabbit IgG was
adsorbed exhaustively with rat blood cells depleted of platelets. For
double-labeling experiments, 5A IgG was coupled with fluorescein
isothiocyanate (FITC).
|
|
Platelets and Bone Marrow Cells
Blood samples for smear slides or platelet isolation were drawn via a polyethylene catheter to a polyvinyl syringe from the aorta of the rats under diethyl ether anesthesia. One milliliter of anticoagulant containing 85 mmol/L sodium citrate, 111 mmol/L dextrose, and 71 mmol/L citric acid per 7 ml of blood was used. Platelets were isolated by the technique of Fox et al15 with slight modifications. To avoid platelet activation, iloprost, a prostacyclin analogue (Ilomedin, Schering Corp.; a generous gift from Leiras Pharmaceutical Co., Helsinki, Finland), 50 ng/ml, was added to the blood. After centrifugation at 200 x gmax for 20 minutes at room temperature, platelet-rich plasmas (PRPs) were obtained. These were further run at 900 x gmax for 20 minutes, and the upper layers of the pellets were resuspended in the original volume of a buffer containing 120 mmol/L sodium chloride, 13 mmol/L sodium citrate, and 30 mmol/L dextrose, pH 7.0. After addition of iloprost, the centrifugation step was repeated, and the pellets were resuspended into Tyrode's buffer containing 138 mmol/L NaCl, 2.9 mmol/L KCl, 12 mmol/L NaHC03, 0.36 mmol/L NaH2PO4, 5.5 mmol/L glucose, 1.8 mmol/L CaCl2, and 0.4 mmol/L MgCl2, pH 7.4, with added iloprost. The suspension was divided into two tubes, and after recentrifugation, the cells were suspended in Tyrode's buffer with added iloprost (nonactivated platelets) or thrombin (10 NIH/ml; Topostasin, Roche, Basel, Switzerland; activated platelets) and incubated at 37°C for 10 minutes. For flow cytometry, paraformaldehyde (final concentration, 3%) was added to the tubes for 10 to 20 minutes at room temperature before antibody incubations (see below). Cytocentrifuge slides were prepared from the nonactivated or activated platelets in a Shandon Cytospin 2 cytocentrifuge (Ashmoore, UK). For immunoblotting experiments, the cells were washed and boiled in the Laemmli sample buffer (see below). For immunoelectron microscopy, the platelets were centrifuged into tiny pellets of 1 mm3 and treated as described below. Isolated platelets were also used for RNA isolation (see below).
Bone marrow tissues were obtained from the femur bones of rats (600 g) anesthetized with diethyl ether. For cytospin preparations, the tissue was dispersed in PBS containing 0.38% sodium citrate and passed three times through a 22-gauge needle before centrifugation. For in situ hybridization experiments, sterile buffer and silanated microscope slides were used.
Immunofluorescence and Flow Cytometry
For IF staining experiments, rat kidneys were frozen rapidly in liquid nitrogen and processed as described earlier.4 Cryostat sections (5 µm thick), smear slides of rat peripheral blood, or cytocentrifuge slides of isolated platelets or bone marrow cells, were fixed in acetone at -20°C for 10 minutes, incubated with the primary and the labeled secondary antibodies at room temperature for 30 minutes each, and embedded in nonfading mounting medium, as described.4 To visualize the nuclei of the marrow cells, Hoechst dye 33258 (0.5 µg/ml; Calbiochem-Behring Corp., La Jolla, CA) was added in the conjugate solution in some experiments. The slides were observed and photographed in an Olympus BX-50 fluorescence microscope equipped with epi-illumination and dichroic mirrors for FITC, TRITC, or UV light.
For flow cytometry experiments, the fixed nonactivated or thrombin-activated platelets were washed twice in PBS, pH 7.2, containing 0.1% NaN3, and suspended in 5% fetal calf serum (FCS; Clone Fetal Calf Serum, PAA Labor- und Forschungges, Linz, Austria) in PBS (PBS-FCS) for 15 minutes to block the nonspecific binding of antibodies. After centrifugation, the cells were incubated in 1 ml of PBS-FCS or PBS-normal rabbit serum containing 1 to 3 µg of monoclonal IgG or 5 µg of adsorbed rabbit IgG, respectively, for 30 minutes, washed three times in PBS with azide, and resuspended in 100 µl of the FITC-anti-mouse or -rabbit IgG diluted in PBS-FCS or in PBS-normal rabbit serum, respectively, for 30 minutes. After three washes in PBS, the cells were suspended in 1 ml of PBS containing 1% paraformaldehyde and analyzed at a Becton-Dickinson FACScan flow cytometer equipped with a 15-mW argon laser emitting light at 480 nm, as described earlier.11 In each analysis, 15,000 thrombocytes gated by their typical forward/side scatter were counted.
Electrophoresis and Western Blotting
For SDS-PAGE, the isolated platelets or detergent extracts of glomeruli were suspended in the Laemmli sample buffer, boiled for 5 minutes, and run under reducing conditions using 5% to 10% gels and a Protean Mini-gel electrophoresis system (Bio-Rad Laboratories, Richmond, CA). For Western blotting, the separated proteins were transferred to nitrocellulose sheets using a Novablot semidry blotting apparatus (Pharmacia, Uppsala, Sweden). The nitrocellulose strips were reacted with antibodies, washed, and incubated with the horseradish-peroxidase-coupled anti-mouse or -rabbit IgG, and the bound antibodies were visualized using the diaminobenzidine H2O2 reaction, as described.4
Immunoelectron Microscopy
For post-embedding immunoelectron microscopy, 1-mm3 pellets of isolated rat platelets were fixed in 0.1 mol/L phosphate containing 3% paraformaldehyde, 0.05% glutaraldehyde, and 0.5 mmol/L CaCl2, pH 7.4, for 2 hours at room temperature, and washed with five changes of 0.1 mol/L phosphate-CaCl2 buffer containing 3.5% sucrose at +4°C overnight. The free aldehyde groups were blocked by incubation in 50 mmol/L NH4Cl made in the same sucrose-CaCl2 buffer at 0°C for 1 hour, and the phosphate ions were washed away in a buffer containing 0.1 mol/L sodium maleate and 3.5% sucrose, pH 6.0, in an ice bath for 15 minutes. This was repeated four times. The pellets were post-fixed in 2% uranyl acetate made in the sucrose-maleate buffer, for 2 hours, dehydrated with acetone, and embedded at -20°C in LR Gold resin (London Resin Co., Hants, UK).16 For antibody labeling, 100- to 150-nm thick sections were cut on 400-mesh nickel grids. To block nonspecific binding sites, the grids were placed on drops of 50 mmol/L TrisHCl buffer containing 150 mmol/L NaCl, pH 7.2 (TBS), and of TBS containing 5% fetal calf serum (TBS-FCS) and thereafter successively on drops of primary antibodies, affinity-purified rabbit anti-mouse IgG, and colloidal gold-labeled goat anti-rabbit IgG. All antibodies were diluted in TBS-FCS, which was used also for washing. After final washing, the grids were fixed in 2% glutaraldehyde for 1 hour, rinsed in water, stained for 15 minutes in 2% aqueous osmium tetroxide, and counterstained in Reynolds lead citrate or in uranyl acetate. The grids were dried and coated with Pioloform-F resin (Polaron Instruments, Hatfield, PA) and studied in a Jeol JEM 100B electron microscope.
Partial Cloning of Rat Podocalyxin
For the glomerular cDNA library, glomeruli were isolated from the kidneys of 10 1-month-old rats, using the sieving technique described earlier.4 Total RNA was prepared from the glomeruli by a modification of the CsCl/guanidine thiocyanate method.17 Polyadenylated mRNA was isolated using PolyATract mRNA isolation System III kit (Promega, Madison, WI) and used to construct a poly(T)-primed directional glomerular library in ZAP Express vector using ZAP Express cDNA Gigapack cloning kit (Stratagene, La Jolla, CA) according to the instructions of the manufacturer. The library was screened with the rabbit PCLP1 cDNA clone DP16 obtained from Dr. David B. Kershaw (University of Michigan, Ann Arbor, MI). The probe was an 868-bp-long ApaI fragment corresponding to nucleotides 1631 to 2499 of PCLP1 mRNA9 and was labeled with [32P]-dCTP using a random priming kit (Boehringer Mannheim). One of the clones obtained (clone 51A) was approximately 4.5 kb and consisted of approximately 4 kb of the 3'-UTR and 555 nucleotides of the carboxyl-terminal region of rat podocalyxin. For Northern blotting experiments, a cDNA probe coding for the expressed sequence of rat podocalyxin (555 nucleotides) and 34 nucleotides of the 3'-UTR was made. For in situ hybridization experiments, 35S-labeled single-stranded antisense or control sense riboprobes, covering the same region as above, were prepared according to Wilcox18 using [35S]-UTP label (>1200 Ci/mmol; DuPont NEN, Boston, MA) and an appropriate SP6/T7 transcription system (Promega). For Northern blotting, total RNA and mRNA were isolated from rat renal cortex. For control purposes, mRNA was isolated from cultured rat kidney epithelial NRK-52E cells (ATTC CRL-1571), not expressing podocalyxin antigens, as previously shown.12
In Situ Hybridization and RT-PCR
For in situ hybridization, kidney tissues were fixed in 4% paraformaldehyde in PBS at +4°C for 4 hours, cryoprotected in 15% sucrose at +4°C in PBS for 16 hours, and frozen on dry ice. Cryostat sections, 5 µm thick, were cut on glass slides treated with 3'-(triethoxysilyl)propylamine (Sigma Chemical Co., St. Louis, MO). In situ hybridization was performed as described earlier19 with slight modifications. Tissue sections or cytocentrifuge slides were fixed in 4% paraformaldehyde for 10 minutes, washed in PBS, and treated with 0.2 mol/L HCl for 5 minutes. After washing in PBS, the slides were incubated in proteinase K (0.25 µg/ml; Merck, Darmstadt, Germany) for 10 minutes, washed again in PBS and distilled water, and acetylated with 26 mmol/L acetic anhydride in 0.1 mol/L triethanolamine, pH 8.0, for 10 minutes. After washing in PBS, the slides were incubated in 50% formamide, 2X SSC for 10 minutes and prehybridized at hybridization conditions for 4 hours without probe. Hybridization with the [35S]-labeled probe (30,000 cpm/µl) was performed in 60% formamide, 5X SSC, 10% dextran sulfate, 1X Denhardt's solution, 100 mmol/L dithiothreitol (DTT), and 0.5 mg/ml yeast tRNA at 53°C for 16 hours. After hybridization, the slides were washed first in 5X SSC, 10 mmol/L DTT at 55°C for 30 minutes followed by 50% formamide, 2X SSC, 10 mmol/L DTT at 65°C for 30 minutes. The slides were then washed three times at 37°C in NTE (0.5 mol/L NaCl, 10 mmol/L TrisHCl, 0.5 mol/L EDTA, pH 8.0) for 10 minutes each, treated with 20 µg/ml ribonuclease A (Merck) in NTE at 37°C for 30 minutes, and washed at 37°C in NTE for 15 minutes. After washing again in 50% formamide, 2X SSC, 10 mmol/L DTT followed by washes in 2X SSC and 0.1X SSC, the slides were dehydrated sequentially in 30%, 60%, 80%, and 94% ethanol containing 0.3 mol/L ammonium acetate and, finally, twice in 100% ethanol. After dipping them in NTB-2 nuclear track emulsion (Kodak), the slides were exposed at 4°C for 7 to 21 days. After development and counterstaining with hematoxylin (Shandon), the slides were investigated and photographed under dark- or bright-field illumination with an Olympus BX-50 microscope.
For RT-PCR, total RNA from isolated rat platelets was DNAse treated (DNAse RQ1, Promega) and reverse transcribed using random hexanucleotide primers (Boehringer Mannheim) and MMLV reverse transcriptase (Promega). The following primers were designed for rat podocalyxin: sense primer 5'-GGT GGC AGT GAA GAG AAT C corresponding to nucleotides 105 to 120 (aa 45 to 49) and antisense primer 5'-CTG TGA GTC GTT GTT GGT C corresponding to nucleotides 355 to 373 (aa 119 to 124). cDNA was amplified using 1 µmol/L primers, 0.2 mmol/L dNTPs, and 1.25 U of AmpliTaq DNA polymerase (Perkin-Elmer Cetus, Norwalk, CT) in buffer containing 10 mmol/L Tris-HCl, pH 8.3, 50 mmol/L KCl, 1.5 mmol/L MgCl2 in the total volume of 25 µl on a thermal cycler (PTC-200; MJ Research, Watertown, MA). The following program was used: first denaturation at 94°C for 3 minutes followed by 30 cycles of denaturation at 94°C for 30 seconds, annealing at 55°C for 30 seconds, and extension at 72°C for 30 seconds. The PCR product was analyzed by agarose gel electrophoresis and ethidium bromide staining, purified (Magic PCR Preps DNA purification and separation kit; Promega), and sequenced directly using gene-specific primers (ABIPrism 310, Perkin-Elmer Applied Biosystems, Foster City, CA).
|
Results |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
The monoclonal (5A and 1A) and the adsorbed polyclonal (290)
anti-podocalyxin IgGs bound to endothelial cells and glomerular
podocytes in a typical manner (Figure 1a)
. The antibodies bound also to
platelets but not to other blood cells on the smear slides of rat
peripheral blood (Figure 1b)
. The staining pattern was granular both in
the resting and thrombin-treated platelets and resembled that obtained
with the anti-CD62P antibodies (Figure 1c)
. Monoclonal anti-annexin I
antibodies gave an intensive staining at polymorphonuclear leukocytes
(not shown) but not at platelets, whereas the anti-megalin or the
anti-O-acetyl GD3 antibodies did not show any binding to rat blood
cells.
On cytospin slides of bone marrow cells, the anti-podocalyxin
antibodies bound to both large polyploid cells and to some smaller
cells (Figure 2a)
. The large cells also
bound the anti-CD62P antibodies (Figure 2b)
, as shown by
double-labeling experiments, indicating that they were megakaryocytes.
Most, but not all, cells positive for podocalyxin were also positive
for CD62P. For both antigens, the staining intensity varied in
individual cells.
|
and the polyclonal
(Figure 3c)
anti-podocalyxin antibodies detected in platelet extracts a
protein with an apparent Mr of 140,000. In
glomerular extracts, the antibodies bound to three protein bands
migrating slightly faster than the platelet protein (Figure 3b and c)
.
At the ultrastructural level, podocalyxin antigens were seen in freshly
isolated platelets mainly at intracellular membranes (Figure 4a)
or at structures resembling
-granules (Figure 4c)
, as shown by post-embedding
immunoelectron microscopy. Anti-megalin or -O-acetyl GD3 IgGs did
not show any binding to platelets (Figure 4b)
.
|
The anti-podocalyxin antibodies showed only limited binding to the
surface of isolated, nonactivated platelets, but the antigens became
detectable at the cell surface after thrombin activation (Figure 5)
. Some platelet activation occurred
during the isolation process, as demonstrated by the binding of the
anti-CD62P antibodies to isolated platelets even before thrombin
treatment.
|
Using the rabbit PCLP1 cDNA clone DP16 from Dr. David Kershaw
(University of Michigan, Ann Arbor, MI), we obtained from our rat
glomerular cDNA library several clones. One of these, clone 51A, was
~4.5 kb and consisted of ~4 kb of 3'-UTR and 555 nucleotides
corresponding to the carboxyl-terminal region of rat podocalyxin and
coding for its putative intracellular, transmembrane, and membrane
proximal extracellular domains (Figure 6)
. The extracellular part included a
seven-amino-acid sequence (AVFELLK) identical to a sequence found
independently by amino acid sequencing of a tryptic peptide from
isolated glomerular podocalyxin. As shown in Figure 6
, the
transmembrane and intracellular domains of rat podocalyxin are 100%
and 93% identical, respectively, with rabbit PCLP1, 96% and 95%,
respectively, with human PCLP, and 69% and 89%, respectively, with
chicken thrombomucin. The intracellular part of rat podocalyxin has one
putative PKC and two CKII consensus phosphorylation sequences, and the
partially cloned extracellular part includes two of the four conserved
cysteins shared by all podocalyxin-like proteins (Figure 6)
, but it
does not extend to the region of the other two. By Northern blotting,
the cDNA probes covering all expressed 185 amino acids of our rat
podocalyxin clone (Figure 6)
hybridized with a 5.5-kb transcript of rat
cortical mRNA but not of the rat epithelial NRK cell mRNA (Figure 7)
. By in situ hybridization,
the corresponding 35S-labeled single-stranded antisense
cRNA probes bound to podocytes and endothelial cells (Figure 8, a and b)
, whereas the sense probes did
not.
|
|
|
By in situ hybridization, the antisense cRNA probe of
rat podocalyxin bound to large megakaryocytic cells and also to some
smaller cells (Figure 9, a and b)
on
cytospin preparations of rat bone marrow. With the sense RNA probes, no
staining over background was seen (Figure 9, c and d)
. Using primers
specific for rat podocalyxin and RT-PCR technique, a PCR product of
expected length (271 bp) was obtained from total RNA extracted from
isolated platelets, but not from NRK cells. No DNA products were seen
in the controls. The RT-PCR products were identical with glomerular
podocalyxin, as shown by direct sequencing.
|
|
Discussion |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Podocalyxin was first discovered as the major sialoprotein of the
glycocalyx of glomerular podocytes1
and was soon found to
be present in the endothelial cells,2
but so far it has not
been found in other rat cell types. Here we show using mono- and
polyclonal antibodies that podocalyxin is present in megakaryocytes and
platelets. These cells readily take up proteins from
plasma20
and store these in the -granules, where
podocalyxin was also detected. Podocalyxin is a membrane protein of
endothelial cells and podocytes, but due to its high carbohydrate
content the molecule is probably hydrophilic and may be present in
plasma. However, our in situ hybridization results clearly
show that podocalyxin mRNA is present in megakaryocytes, and by RT-PCR,
podocalyxin mRNA could also be demonstrated in RNA extracted from
platelets. Thus, it is evident that rat megakaryocytes make podocalyxin
themselves.
Rat podocalyxin resembles the podocalyxin-like protein thrombomucin of
chicken, present on podocytes, endothelial cells, and
thrombocytes.8
Thrombomucin is one of the earliest markers
of hematopoietic cells in chicken embryos, and in adult bone marrow it
is found on the surface of multipotent hematopoietic progenitors as
well as on erythroid and thrombocyte precursors.8
In rat
bone marrow, anti-podocalyxin antibodies detected cells of different
sizes and different staining intensity. All were not positive for
CD62P, a marker for megakaryocytic cells (Figure 2a)
. Whether the
podocalyxin-positive and CD62P-negative cells are at an earlier
megakaryocytic developmental stage or of different cell lineage remains
to be studied. At present, no data of human or rabbit podocalyxin-like
proteins in bone marrow cells are available, but our results suggest
that podocalyxin may have a role in hematopoiesis also in mammals.
In glomeruli or lung tissues, intact podocalyxin has an apparent
Mr of 140,000, but in detergent extracts only
smaller, 110 to 140-kd molecular forms are usually detected by Western
blotting.1,2,4,5
The platelet protein migrates slightly
slower than the glomerular forms in SDS-PAGE (Figure 3, B and C)
. The
different antigenic forms may be due to enzymatic degradation or
post-translational modifications of the protein, or may indicate
existence of different splice variants. Cell-type-specific differences
in glycosylation have been reported with human PCLP, which may carry
MECA-79 epitopes at the surface of high endothelia of peripheral lymph
nodes,21
whereas PCLP at other endothelia21
or
glomerular podocytes22
do not express this epitope. Changes
in the glycosylation pattern may have significant effects on the
apparent Mr of the protein. The calculated
molecular masses of the known chicken, rabbit or human PCLPs are 54 or
55 kd, but their apparent Mr values vary from
140,000 to 165,000/160,000. It is assumed that this is due to the rich
mucin-type glycosylation of the molecules. Different splice variants of
both chicken thrombomucin and rabbit PCLP1 apparently exist. Whether
this is true also for rat podocalyxin is not known.
Rabbit podocalyxin-like protein 1, human podocalyxin like protein, and
chicken thrombomucin do not show sequence homology to any previously
described proteins, but the membrane spanning and intracellular domains
of each are highly homologous,8-10
indicating that they
belong to the same protein family. The extracellular parts are less
homologous but share a mucin-like structure and four conserved
cysteins. All intracellular domains share PKC and casein kinase II
phosphorylation consensus sequences, suggesting that the proteins may
be involved in signaling events. Our data show that the putative
transmembrane and intracellular parts of rat podocalyxin are almost
identical with rabbit PCLP1 and human PCLP, including the
phosphorylation consensus sequences, and the membrane proximal
extracellular part has two of the conserved cysteins in their right
positions (Figure 6)
. This agrees with the earlier data of Kershaw et
al,10
who demonstrated antigenic cross-reactivity between
the intracellular parts of human PCLP and rat podocalyxin. The cloned
cDNA does not extend to the putative mucin-like domain, but earlier
data have shown that ~20% of glomerular podocalyxin consists of
carbohydrates, both N- and O-linked side chains are present, and both
of these may carry sialic acid and sulfate residues.5,24
These are all features of mucin-type glycoproteins and clearly show
that rat podocalyxin is a member of the PCLP family.
The functions of podocalyxin are not known. In the developing kidney it is detected in endothelial cells and differentiating podocytes already at the early S-shaped body stage.6,7 As the podocytes mature, podocalyxin occupies the membranes above the occluding junctions, suggesting that its role may be to keep the urinary filtration slits open.1,5,6 In endothelial cells it may also help to keep the vascular lumina open and/or repel circulating cells, although in some endothelia it may also have adhesive functions.21 At present, only speculations on the functions of podocalyxin in megakaryocytes or platelets can be presented. Our finding that podocalyxin becomes detectable at the platelet surface first after thrombin stimulation suggests that it may have an activation-dependent function in these cells. The regulation of podocalyxin synthesis, glycosylation, and expression at the cell surface remains to be studied, as also its putative functions in hematopoiesis and/or in platelet-endothelial interactions.
|
Acknowledgements |
|---|
|
Footnotes |
|---|
Supported by grants from Helsinki University Central Hospital, The Sirkka and Sakari Sohlberg Foundation, The Paulo Foundation, and The Academy of Finland.
Accepted for publication November 30, 1998.
|
References |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
This article has been cited by other articles:
 |
|
 |
|
  S. Sizemore, M. Cicek, N. Sizemore, K. P. Ng, and G. Casey Podocalyxin Increases the Aggressive Phenotype of Breast and Prostate Cancer Cells In vitro through Its Interaction with Ezrin Cancer Res., July 1, 2007; 67(13): 6183 - 6191. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Doyonnas, J. S. Nielsen, S. Chelliah, E. Drew, T. Hara, A. Miyajima, and K. M. McNagny Podocalyxin is a CD34-related marker of murine hematopoietic stem cells and embryonic erythroid cells Blood, June 1, 2005; 105(11): 4170 - 4178. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Somasiri, J. S. Nielsen, N. Makretsov, M. L. McCoy, L. Prentice, C. B. Gilks, S. K. Chia, K. A. Gelmon, D. B. Kershaw, D. G. Huntsman, et al. Overexpression of the Anti-Adhesin Podocalyxin Is an Independent Predictor of Breast Cancer Progression Cancer Res., August 1, 2004; 64(15): 5068 - 5073. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. G. Economou, P. V. Kitsiou, A. K. Tzinia, E. Panagopoulou, E. Marinos, D. B. Kershaw, D. Kerjaschki, and E. C. Tsilibary Enhanced podocalyxin expression alters the structure of podocyte basal surface J. Cell Sci., July 1, 2004; 117(15): 3281 - 3294. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Rantanen, T. Palmen, A. Patari, H. Ahola, S. Lehtonen, E. Astrom, T. Floss, F. Vauti, W. Wurst, P. Ruiz, et al. Nephrin TRAP Mice Lack Slit Diaphragms and Show Fibrotic Glomeruli and Cystic Tubular Lesions J. Am. Soc. Nephrol., June 1, 2002; 13(6): 1586 - 1594. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Simons, K. Schwarz, W. Kriz, A. Miettinen, J. Reiser, P. Mundel, and H. Holthofer Involvement of Lipid Rafts in Nephrin Phosphorylation and Organization of the Glomerular Slit Diaphragm Am. J. Pathol., September 1, 2001; 159(3): 1069 - 1077. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Doyonnas, D. B. Kershaw, C. Duhme, H. Merkens, S. Chelliah, T. Graf, and K. M. McNagny Anuria, Omphalocele, and Perinatal Lethality in Mice Lacking the CD34-related Protein Podocalyxin J. Exp. Med., June 25, 2001; 194(1): 13 - 28. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Takeda, W. Y. Go, R. A. Orlando, and M. G. Farquhar Expression of Podocalyxin Inhibits Cell-Cell Adhesion and Modifies Junctional Properties in Madin-Darby Canine Kidney Cells Mol. Biol. Cell, September 1, 2000; 11(9): 3219 - 3232. [Abstract] [Full Text]
|
|
|
|
 |
|
 C. Sassetti, A. Van Zante, and S. D. Rosen Identification of Endoglycan, a Member of the CD34/Podocalyxin Family of Sialomucins J. Biol. Chem., March 17, 2000; 275(12): 9001 - 9010. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Ahola, S.-X. Wang, P. Luimula, M.-L. Solin, L. B. Holzman, and H. Holthofer Cloning and Expression of the Rat Nephrin Homolog Am. J. Pathol., September 1, 1999; 155(3): 907 - 913. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Li, J. Li, S. W. Straight, and D. B. Kershaw PDZ domain-mediated interaction of rabbit podocalyxin and Na+/H+ exchange regulatory factor-2 Am J Physiol Renal Physiol, June 1, 2002; 282(6): F1129 - F1139. [Abstract] [Full Text] [PDF]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
) consensus
phosphorylation sites, and its partially cloned extracellular domain
extends to include two of the four conserved cysteins (arrows).
The extracellular seven-amino-acid sequence (aa
50 to 56, line above) was found independently by
amino acid sequencing of tryptic peptides of isolated rat glomerular
podocalyxin. The probes used for Northern blotting or in
situ hybridization covered the whole area shown. Numbering is
according to the sequences in GenBank. Accession numbers are 
